Subcutaneous Epcoritamab Shows Promise in Some Non-Hodgkin Lymphoma Patients
09/27/2021

Subcutaneous Epcoritamab Shows Promise in Some Non-Hodgkin Lymphoma Patients

NEW YORK (Reuters Health) – Single-agent subcutaneous epcoritamab appears to benefit patients ...
read more